
Megmazid-T Injection
Marketer
Ridhima Biocare
Salt Composition
Ceftazidime (1000mg) + Tazobactum (125mg)
Overview Megmazid-T Injection
Triazid-T Injection combines multiple medications to combat diverse bacterial infections. Its action inhibits microbial growth, thus curbing infection spread. Administration should always occur under a doctor's direct supervision. Consistent adherence to the prescribed treatment schedule is crucial; incomplete courses risk treatment failure. Interrupting treatment prematurely may reduce its effectiveness. Nausea, vomiting, diarrhea, and digestive upset are potential side effects. Severe side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, breathing difficulties) require prompt emergency care. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals must consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While usually non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are essential for optimal recovery. Your physician might order tests to monitor the medication's impact on your body.
Primary Ingredients of Megmazid-T Injection
No text was provided to rewrite.
Uses of Megmazid-T Injection
Infections caused by bacteria
Major Benefits of Megmazid-T Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Megmazid-T Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Megmazid-T Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Megmazid-T Injection works:
Megmazid-T Injection unites Ceftazidime, a bacterial growth inhibitor, and Tazobactum, a beta-lactamase inhibitor. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counters bacterial resistance mechanisms, thereby boosting Ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Megmazid-T Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The use of Megmazid-T Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Use of Megmazid-T Injection while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no appreciable risk to the infant.
DrivingUNSAFE
Administration of Megmazid-T Injection can lead to reduced awareness, visual impairment, drowsiness, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should use Megmazid-T Injection with careful monitoring. Dosage modification of Megmazid-T Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Megmazid-T Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Megmazid-T Injection :
Should you forget a scheduled Megmazid-T Injection, seek medical advice immediately.
Facts to Know About Megmazid-T Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
